MICHAEL H DOSIK, M.D.
Osteopathic Medicine at Conscience Cir, Strongs Neck, NY
License number
New York 114608
Category
Osteopathic Medicine
Type
Hematology & Oncology
Address
Address
22 Conscience Cir, Strongs Neck, NY 11733
Phone
(631) 751-5421
(631) 751-7452 (Fax)
(631) 751-7452 (Fax)
Professional information
Elf3 Gene Compositions And Methods
US Patent:
2010031, Dec 16, 2010
Filed:
May 17, 2010
Appl. No.:
12/800539
Inventors:
Mark H. Kaplan - Ann Arbor MI, US
Michael H. Dosik - East Setauket NY, US
Xue-Ping Wang - Port Washington NY, US
Michael H. Dosik - East Setauket NY, US
Xue-Ping Wang - Port Washington NY, US
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
ELF3 gene compositions associated with cancer are provided, including ELF3 mRNA intron retention, a novel ELF3 5′ untranslated region, and a novel Alu, Alu. Methods and kits using primers or probes to detect the presence of these ELF3 gene compositions are also provided. Methods for determining whether a cell comprises a virus are also provided.
Elf3 Gene Compositions And Methods
US Patent:
7718783, May 18, 2010
Filed:
Nov 21, 2003
Appl. No.:
10/535378
Inventors:
Mark H. Kaplan - Ann Arbor MI, US
Michael H. Dosik - East Setauket NY, US
Xue-Ping Wang - Port Washington NY, US
Michael H. Dosik - East Setauket NY, US
Xue-Ping Wang - Port Washington NY, US
International Classification:
C07H 21/02, C12Q 1/68
US Classification:
536 231, 435 6
Abstract:
ELF3 gene compositions associated with cancer are provided, including ELF3 mRNA intron retention, a novel ELF3 5′ untranslated region, and a novel Alu, Alu. Methods and kits using primers or probes to detect the presence of these ELF3 gene compositions are also provided. Methods for determining whether a cell comprises a virus are also provided.
Herv Group Ii Viruses In Lymphoma And Cancer
US Patent:
2008026, Oct 23, 2008
Filed:
Sep 10, 2007
Appl. No.:
11/852369
Inventors:
David Markovitz - Ann Arbor MI, US
Mark H. Kaplan - Ann Arbor MI, US
Michael H. Dosik - Setauket NY, US
Mark H. Kaplan - Ann Arbor MI, US
Michael H. Dosik - Setauket NY, US
Assignee:
The Regents of the University of Michigan - Ann Arbor MI
International Classification:
C12Q 1/68, G01N 33/574, C12Q 1/02
US Classification:
435 6, 435 723, 435 29
Abstract:
The present invention relates to compositions and methods for cancer diagnosis and therapy, including but not limited to, cancer markers. In particular, the present invention relates to HERV-K(HML-2) target titers as diagnostic markers, and HERV-K(HML-2) therapeutic targets for HIV-related cancers, and other cancers.